Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Hematol Oncol Stem Cell Res
Autori principali: Poopak, Behzad, Rabieipoor, Saghar, Safari, Nazila, Naraghi, Emadedin, Sheikhsofla, Fatemeh, Khosravipoor, Gelareh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://ncbi.nlm.nih.gov/pubmed/26865929
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi